Autor: |
Janelsins MC; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Heckler CE; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Peppone LJ; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Kamen C; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Mustian KM; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Mohile SG; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Magnuson A; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Kleckner IR; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Guido JJ; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Young KL; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Conlin AK; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Weiselberg LR; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Mitchell JW; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Ambrosone CA; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Ahles TA; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH., Morrow GR; Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, and Gary R. Morrow, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester; Lora R. Weiselberg, North Shore LIJ Health System-National Cancer Institute Community Clinical Oncology Research Program (NCORP), Lake Success; Christine A. Ambrosone, Roswell Park Cancer Institute, Buffalo; Tim A. Ahles, Memorial Sloan Kettering Cancer Center, New York, NY; Kelley L. Young, Kansas City Clinical Oncology Program, Kansas City, MO; Alison K. Conlin, Pacific Cancer Research Consortium NCORP, Seattle, WA; and Jerry W. Mitchell, Columbus NCORP, Columbus, OH. |